Acute Respiratory Infections
12
1
1
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 12 trials
100.0%
+13.4% vs benchmark
17%
2 trials in Phase 3/4
10%
1 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 10 completed trials
Clinical Trials (12)
Efficacy of Ultraviolet Germicidal Irradiation Devices to Reduce Respiratory Infections in Nursing Homes: Cluster Randomized Crossover Trial
Serum Vitamin D Status in Critically Ill Children With Acute Respiratory Infections
The Fever Clinic Acute Respiratory Cohort
Echinacea and Acute Respiratory Illness
C Reactive Protein (CRP) Intervention to Reduce Inappropriate Antibiotic Prescriptions in the Primary Healthcare Setting
A Study to Determine the Causes and Identify Increases in Influenza-Like Illness (ILI) in Mexico
Evaluation of Novel Antimicrobial Hand Towels
Pain and Stress Assessment in Children
DECISION+, a Training Program to Improve Optimal Drug Prescription
Treatment of Acute Sinusitis
Role of Zinc in Recurrent Acute Lower Respiratory Infections
Trial of Amoxicillin Compared With Placebo for Pneumonia in Children Aged 2-59 Months